« CleveMed Releases New Version of KinetiSense Motion Analysis System
DreamPort™ and Research »

DreamPort ushers in
concept of attended PSG Anywhere

September 3rd, 2009 by Jerusha Michael

CleveMed’s DreamPort, expands the reach of your sleep business by allowing remotely attended sleep studies to be done from anywhere, using a bedside system controlled by sleep technologists miles away – over the internet. Broadband technology combined with a camera is used to transmit the patient data and video in real-time, allowing studies to be conducted anywhere the patient is.

  • DreamPort is particularly ideal for those who are unable or reluctant to make it into the sleep lab, such as pediatric patients, cross country truckers, the elderly, those suffering from chronic pain and hospital inpatients.
  • In addition, this system gives clinicians and researchers greater flexibility to conduct sleep studies anywhere. DreamPort is suitable for clinical trials as it allows for cost effective research studies to be conducted in the patient’s home while adding an additional element of home care.
  • DreamPort combines the comfort and cost-effectiveness of home testing with the peace of mind of an attended study.
    • Dr. Golish, is a board-certified specialist in sleep medicine and author of more than 300 publications on sleep. He is a member of the Sleep Steering Committee for the ACCP. After 35 years as a professor in The Cleveland Clinic and Co-Director of Sleep Medicine, he has left academic medicine to advance a new paradigm in sleep medicine, focusing on accessibility and affordability. His goals are the proper use of HST and fostering continuity of care, in an efficient and cost-effective manner, while preserving high quality. He is currently the Medical Director of Cleveland Medical Devices (CleveMed) and Director of Sleep Center, North Coast Clinical Trials, in Cleveland, Ohio.

    Tags: , , ,

    This entry was posted on Thursday, September 3rd, 2009 at 3:44 pm and is filed under Sleep Disorders. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

    Leave a Reply